Marcus Ruscetti

2.3k total citations
26 papers, 1.5k citations indexed

About

Marcus Ruscetti is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Marcus Ruscetti has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Marcus Ruscetti's work include Immune cells in cancer (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (6 papers). Marcus Ruscetti is often cited by papers focused on Immune cells in cancer (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (6 papers). Marcus Ruscetti collaborates with scholars based in United States, China and Canada. Marcus Ruscetti's co-authors include Hong Wu, David J. Mulholland, Linh M. Tran, Naoko Kobayashi, Jiaoti Huang, Martin Gleave, Eman L. Dadashian, Loretah Chibaya, Yu-Jui Ho and Scott W. Lowe and has published in prestigious journals such as Science, Cell and Journal of Clinical Investigation.

In The Last Decade

Marcus Ruscetti

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Ruscetti United States 10 750 676 390 378 326 26 1.5k
Eriko Katsuta United States 24 773 1.0× 695 1.0× 372 1.0× 403 1.1× 501 1.5× 82 1.6k
Magdalena Karbowniczek United States 20 922 1.2× 530 0.8× 437 1.1× 349 0.9× 179 0.5× 30 1.8k
Edward L. LaGory United States 18 927 1.2× 312 0.5× 242 0.6× 256 0.7× 718 2.2× 25 1.5k
Janelle Simon United States 11 993 1.3× 727 1.1× 504 1.3× 132 0.3× 379 1.2× 13 2.0k
Nilgun Tasdemir United States 15 1.1k 1.5× 429 0.6× 183 0.5× 176 0.5× 349 1.1× 26 1.6k
Alexandra Avgustinova Spain 10 1.2k 1.6× 532 0.8× 308 0.8× 178 0.5× 919 2.8× 13 1.9k
Robert J. Norgard United States 13 1.1k 1.4× 1.1k 1.6× 340 0.9× 204 0.5× 670 2.1× 16 2.0k
Jae‐Seok Roe South Korea 22 1.6k 2.2× 376 0.6× 249 0.6× 230 0.6× 479 1.5× 45 2.1k
Sébastien Tabariès Canada 20 1.0k 1.4× 573 0.8× 317 0.8× 224 0.6× 788 2.4× 27 1.8k
Defeng Deng United States 18 703 0.9× 476 0.7× 280 0.7× 128 0.3× 362 1.1× 29 1.3k

Countries citing papers authored by Marcus Ruscetti

Since Specialization
Citations

This map shows the geographic impact of Marcus Ruscetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Ruscetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Ruscetti more than expected).

Fields of papers citing papers by Marcus Ruscetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Ruscetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Ruscetti. The network helps show where Marcus Ruscetti may publish in the future.

Co-authorship network of co-authors of Marcus Ruscetti

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Ruscetti. A scholar is included among the top collaborators of Marcus Ruscetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Ruscetti. Marcus Ruscetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Calvin W., Emma E. Furth, Karl Simin, et al.. (2025). Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. Cell Reports. 44(5). 115627–115627. 2 indexed citations
2.
Murphy, Katherine C., Lin Zhou, Yu-Jui Ho, et al.. (2025). MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer. Cancer Research. 85(22). 4359–4379. 1 indexed citations
3.
Perego, Michela, Ekta Agarwal, Irene Bertolini, et al.. (2025). Parkin activates innate immunity and promotes antitumor immune responses. Journal of Clinical Investigation. 135(2).
4.
Sun, Wenlong, Fu Gui, Marcus Ruscetti, et al.. (2025). SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations. Bioconjugate Chemistry. 36(10). 2158–2171.
5.
Murphy, Katherine C., et al.. (2024). Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer. Methods in cell biology. 190. 171–201. 2 indexed citations
6.
Ruscetti, Marcus. (2024). Abstract SoA2-01: Cellular senescence: The senescence-associated secretory phenotype (SASP) and immunity. Cancer Research. 84(9_Supplement). SoA2–1. 1 indexed citations
7.
Alcolea, Maria P., Direna Alonso‐Curbelo, Chiara Ambrogio, et al.. (2024). Cancer Hallmarks: Piecing the Puzzle Together. Cancer Discovery. 14(4). 674–682. 7 indexed citations
8.
Chibaya, Loretah, Katherine C. Murphy, Jason R. Pitarresi, et al.. (2024). Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer. Science Translational Medicine. 16(762). eadj9366–eadj9366. 25 indexed citations
9.
Perego, Michela, Ekta Agarwal, Irene Bertolini, et al.. (2024). Parkin activates innate immunity and promotes antitumor immune responses. Journal of Clinical Investigation. 134(22). 4 indexed citations
10.
11.
Zhou, Lin, et al.. (2024). Cellular senescence offers distinct immunological vulnerabilities in cancer. Trends in cancer. 11(4). 334–350. 9 indexed citations
12.
Murphy, Katherine C. & Marcus Ruscetti. (2023). Advances in Making Cancer Mouse Models More Accessible and Informative through Non-Germline Genetic Engineering. Cold Spring Harbor Perspectives in Medicine. 14(4). a041348–a041348. 3 indexed citations
13.
Zhou, Lin, et al.. (2023). Abstract A028: Dissecting the role of cellular senescence in prostate cancer initiation and immune suppression. Cancer Research. 83(11_Supplement). A028–A028.
14.
Chibaya, Loretah, et al.. (2022). Senescence and the tumor-immune landscape: Implications for cancer immunotherapy. Seminars in Cancer Biology. 86(Pt 3). 827–845. 88 indexed citations
15.
Ruscetti, Marcus, John P. Morris, Riccardo Mezzadra, et al.. (2020). Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 181(2). 424–441.e21. 281 indexed citations
16.
Zou, Yongkang, Zhi Qi, Weilong Guo, et al.. (2018). Cotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3Kα/β/δ Inhibitor BAY1082439. Molecular Cancer Therapeutics. 17(10). 2091–2099. 6 indexed citations
17.
Ruscetti, Marcus, Josef Leibold, Matthew J. Bott, et al.. (2018). NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 362(6421). 1416–1422. 268 indexed citations
18.
Ruscetti, Marcus, et al.. (2015). Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Research. 75(13). 2749–2759. 173 indexed citations
19.
Ruscetti, Marcus, Eman L. Dadashian, Weilong Guo, et al.. (2015). HDAC inhibition impedes epithelial–mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene. 35(29). 3781–3795. 102 indexed citations
20.
Mulholland, David J., Naoko Kobayashi, Marcus Ruscetti, et al.. (2012). Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells. Cancer Research. 72(7). 1878–1889. 385 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eriko Katsuta Breakdown of academic impact, for papers by Magdalena Karbowniczek Breakdown of academic impact, for papers by Edward L. LaGory Breakdown of academic impact, for papers by Janelle Simon Breakdown of academic impact, for papers by Nilgun Tasdemir Breakdown of academic impact, for papers by Alexandra Avgustinova Breakdown of academic impact, for papers by Robert J. Norgard Breakdown of academic impact, for papers by Jae‐Seok Roe Breakdown of academic impact, for papers by Sébastien Tabariès Breakdown of academic impact, for papers by Defeng Deng
Rankless by CCL
2026